Latest News

Oxford Covid vaccine safe for older adults: results

A leading Covid-19 vaccine candidate has shown to safely produce a robust immune response in healthy older adults, its British makers said recently as it released its phase 2 trial results.

The vaccine, developed by the University of Oxford and AstraZeneca, produced fewer side effects in people aged 56 and over than in younger people — a significant finding given that Covid-19 disproportionately causes severe illness among seniors.

The manufacturers said the vaccine was undergoing larger, more comprehensive phase 3 trials to confirm the results.

Immune responses from vaccines tend to lessen as people get older as the immune system gradually slows with age.

-Courtesy by AFP

November 20, 2020

Leave a Reply

Your email address will not be published. Required fields are marked *

Dental is part of the Medical News Group of publications which in 1968 became the pioneer of medical journalism in Pakistan. Medical News is the only periodical in Pakistan which has 3 simultaneous editions from Karachi, Islamabad and online.

For Subscription